Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction - Contacts and Locations

Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction

This study has been completed.

Study NCT00045318. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00045318

Locations


United States, California
	Jonsson Comprehensive Cancer Center, UCLA
	Los Angeles, California, United States, 90095

United States, Texas
	Brooke Army Medical Center
	Fort Sam Houston, Texas, United States, 78234
	Cancer Therapy and Research Center
	San Antonio, Texas, United States, 78229
	St. Luke's Lutheran Hospital
	San Antonio, Texas, United States, 78229
	Veterans Affairs Medical Center - San Antonio (Murphy)
	San Antonio, Texas, United States, 78284

Sponsors and Collaborators

Jonsson Comprehensive Cancer Center

National Cancer Institute (NCI)

Investigators


Study Chair:	Carolyn Britten, MD	Jonsson Comprehensive Cancer Center